CAR-T

Aaron Reid, 20, rests in an exam room in the National Institutes of Health Clinical Center in Bethesda, Md.

Health & Safety

Update: A Young Man's Experiment With A 'Living Drug' For Leukemia

4:39pm September 14, 2018

After trying one treatment after another for his leukemia, 20-year old Aaron Reid enrolled in a study to test an experimental therapy using modified cells from his own body.

Queue Listen Now

Some critically ill patients who received a CAR-T cell treatment have remained cancer-free for as long as five years, researchers say. But the price is high.

National
Science
Health & Safety

Insurers And Government Are Slow To Cover Expensive CAR-T Cancer Therapy

3:36pm July 17, 2018

by Michelle Andrews

Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.